FIELD: medicine.
SUBSTANCE: preserving the myocardium in transplantation involves perfusion and storage of the isolated heart with using a Custodiol solution at a temperature of 2-4°C. The heart tissue culture into the donor precedes a 10-12-hour infusion of Levosimendan 10 mcg/kg of body weight, while the perfusion and storage of the isolated organ is ensured by adding Levosimendan into the Custodiol solution at 10 mcg of the preparation per 1 litre of the solution. The surgical stage of the heart transplantation after the recipient's aorta de-clamping and the blood flow recovery is followed by introducing Levosimendan 12.5 mg into the continuing bypass circuit and infusing it for 1 hour.
EFFECT: invention aims at preventing the ischemic and re-perfusion myocardial injuries, providing the adequate function of the donor's heart in the recipient's body.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RECONDITIONING A DONOR HEART | 2021 |
|
RU2777097C1 |
DEVICE FOR EXTRACORPOREAL MECHANICAL PERFUSION OF DONOR ORGANS INSIDE DONOR'S BODY | 2014 |
|
RU2570391C1 |
METHOD OF EXTRACORPORAL RECOVERY OF PERFUSION AND OXYGENATION IN DONOR BODY | 2017 |
|
RU2666515C2 |
METHOD OF RECOVERING VIABILITY OF ISCHEMICALLY AFFECTED DONOR ORGANS | 2009 |
|
RU2423931C2 |
METHOD FOR RESTORATION AND MAINTENANCE OF VITALITY OF AN ISCHEMICALLY DAMAGED DONOR ORGAN | 2010 |
|
RU2441608C1 |
METHOD FOR OBTAINING KIDNEY TRANSPLANTS FROM DONORS WITH OUT-OF-HOSPITAL CIRCULATORY ARREST | 2023 |
|
RU2821024C1 |
METHOD FOR EXTRACORPOREAL FLEXIBLE LASER LITHOTRIPSY OF CADAVERIC DONOR KIDNEY UNDER CONDITIONS OF COLD ISCHEMIA | 2024 |
|
RU2823461C1 |
METHOD FOR PREDICTING THE RISK OF EARLY CADAVERIC LIVER TRANSPLANT DYSFUNCTION | 2021 |
|
RU2765462C1 |
APPARATUS FOR PERFUSION PRESERVATION AND RECONDITIONING OF A DONOR HEART | 2020 |
|
RU2754592C1 |
METHOD FOR PREVENTION OF REPERFUSION INJURIES OF DONOR ORGANS | 2011 |
|
RU2487704C2 |
Authors
Dates
2014-12-10—Published
2013-09-26—Filed